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Weconclude.thatassemblageof uPAR,Jakl andTyk2in one receptor
complexindicatesthefunctionalcooperationof the uPARandtheJakfSTAT
pathwayasoneregulatorfor SMCandECmigrationandproliferation.





We havereportedthat cardioprotectionin ischemicpreconditioning(IP) is
attributableto activationof ecto-5’-nucbotidase(ecto-5’-NT),the enzyme
responsiblefor adenosineproductionin the caninemyoosrdiumand that
ecfo-5’-NTis activatedby proteinkinaseC (PKC).However,there is no
directevidencethat scto-5’-NTis the substratefor PKCinthe myocardium.
ReexaminedwhetherPKCphoaphotylatesecto-5’-NTofthecanineprecon-
ditionedmyooardium.Intheopenchestdogs,1Pwasproducedby4timesof
5 mincoronatyocclusionwitha 5-reininterval(n = 5). In anotherdogs,we
administeredPMA(0.5pmolJkg/min)intothecoronatyarteryfor4 timesof 5
minwitha 5-reininterval(n = 5). Fiveminafter1Pand PMAprocedure,we


























II (Angll)or its by-productthe hexapeptide(3-6) fragmentAngiotensinIV
(AnglV).IntwentyfournormalNewZealandWhiterabbits,Angll (n= 6)and
AnglV(n = 6) were infusedat gradedconcentration(2,4 and6 @kg/rein)
over160minutes.Meanlevelsof PAI-I activityincreasedsignificantlyin a
dosedependentmannerfrom (4 * 3.7 ng/mL)beforeAngll infusionto (26
+ 3.3 nglmL)at the end of Angll infusion(p < 0.00001)and from (1.1+
1.02ng/mL)beforeAnglVinfusionto (27 * 3.7 n@mL)at the endof AnglV
infusion(p = < 0.00001),whereasPAI-1activitydecreasedin the control
groupinfusedwithnormalsaline(n= 6), from(4.8* 1.5ng/mL)to (1 * 0.5
n@mL)(p= < 0.001).Theanimalsthatwerepretreatedwithamastetin(Angll
receptorblocker,n = 6) priorto receivinggradedinfusionof Angll,exhibitad
theexpectedrisein bloodpressurewhilethe PAI-Iactivityweesignificantly
reduced(6.7+ 2.1 ng/mL)in comparisonto the infusionof Angllalone(p =
< O.00001).
Conclusion:TheseIn vivodatastronglysuggestthatthe increaseinthe
circulatinglevelsof PAI-1inducedby the renin-angiotensinsystemmaybe
secondaryto bothAngll andAnglV.




The Marfansyndromehas been linkedto the extracellularmatrixprotein
fibrillin-1(FBN1)whichaggregatesto forminsolublemicrofibrils.Mutations
in the FBNI gene resultin abnormalpatternsof synthesis,secretionand
matrixdepositionof FBN1in dermal fibroblasteas weli as reducedim-






maintainedfor an additionalperiod(2Qculture),FBNI in the tissueculture
mediumcouldreadilybe separatedfrom an intracellularand extracellular
microfibrillarform.Whilethesynthesisof FBNIwasnotaffected,theamount
of insoluble,microfibrillarFBN1wasquitesensitiveto cultureconditionsin
the IQcultureas wellas the 2Qculture.Trypsinizationof labeledfibrobieets
underconditionsusedfor replatingof cellsshowedincompletedigestionof








is observed.Ourdata indicatethat the pulsechaseassaymeasuresa re-
ductionin FBN1depositionin suchfibroblasts,sincefewermicrofibrilsare
availablefor the depositionof a labeledFBNI moleculeduringthe chase
period.Alteredmicrofibrillarstructuresassembledin culturemayalsooon-









patients,we identifieda missensemutationin exon 7 in the eNOSgene
by directDNAsequencing:a G to T transitionthat changedGlum (GAG)
to Asp (GAT).We screenedthis mutationin CAG proven-CHDpatients
(n = 432) and normalcontrols(n = 207). The variantdistributionof this





markedlyhigherthanthat in patients(n = 56)withoutrestenosia(27.1%vs
lp.s~o, ,y2 = 4.638,p = 0.031).MultipleIbgisticregressionanalysisrevealad
a significantassociationbetweenthe riskof CHDandthis eNOSmieaense
mutation(p = 0.032).To evaluatethe possibilityof an interactionbetween
this mutationandACEl/D polymorphismon the riskof CHD,we screened
theACEl/Dgenotypes.Invariantswiththismutation,theoddsratioforCHD
associatedwith the ACE DD genotypewas 4.71 (2.32+56, p = 0.039).
Amongpatientsdefinedas low-risk(serumapo B e 1.25@L,BMi <26
kg/m2,non-HT,non-DM,andnon-smoking),this interactionis evenstronger
[oddsratio:11.56(5.15-25.91,p = 0.010)].Cone/uaions:1. The frequency
of the GIu2W+Aspmissensemutationof the eNOSgenewasestablished
inJapanesecontrolsandCHDpatients;2. Thismutationmaybeassociated








Weexaminedtheeffectsof intrapericerdialdeliveryof a replication-deficient
adenoviruscarryingthecDNAforvascularendotheliaigrowthfactor(AdCMV.
VEGFls5)onmyccerdialangiogenesisinanestablisheddogcoiiateralmwlel.
Ameroidconstrictorswereplacedon the proximalleft ciroumfiexcoronary
arteryofdogs.Tendayslater,6 x 109pfuAdCMV.VEGF(n=5), AdRSV.@
(n = 4), or saline(n =7) weredeliveredthroughan indwellingpericerdial
catheter.Transfaotionefficiencywashigh,withextensive~gslstaininginthe
epi- and pericardium.Perfoardialand aerumVEGFlevelswere measured
byELISAin6 dogs(averagevaluesshown).Collateralperfusion,essessed
withrediolabeledmicroapheres26dayspoet-Rx,weesimilarin all groups.
